Item | Screening | Treatment | Follow-up | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Session | 1 (baseline) | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 (+1 m) | 18 (+2 m) | 19 (+3 m) |
Eligibility screening | √ | ||||||||||||||||||
Informed consent | √ | ||||||||||||||||||
Patient preference screening | √ | ||||||||||||||||||
Allocation | √ | ||||||||||||||||||
Patient expectation toward treatment | √ | ||||||||||||||||||
Treatment | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | ||||
Widespread pain index | √ | √ | √ | √ | √ | √ | √ | ||||||||||||
Symptom severity | √ | √ | √ | √ | √ | √ | √ | ||||||||||||
Visual analogue score | √ | √ | √ | √ | √ | √ | √ | ||||||||||||
Fibromyalgia intensive questionnaire | √ | √ | √ | √ | √ | ||||||||||||||
Hamilton depression scale | √ | √ | √ | √ | √ | ||||||||||||||
SF-36 Health survey | √ | √ | √ | √ | √ | ||||||||||||||
Patient satisfaction of treatment | √ | ||||||||||||||||||
Number of dropouts or lost to follow-up | √ | √ | |||||||||||||||||
Practitioner attitude toward research model | √ | √ | |||||||||||||||||
Recording of adverse events | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ |